ORIGINAL RESEARCH
Published on 29 Apr 2025
IGFBP5 mediates the therapeutic effect of isoliquiritigenin in myocardial ischemia-reperfusion injury via AKT/GLUT4 regulated insulin resistance
doi 10.3389/fphar.2025.1544869
- 1,140 views
- Frontiers in Pharmacology
- Cardiovascular and Smooth Muscle Pharmacology
- Research Topics
- Cardiometabolic Diseases: Therapeutic Targets Discovery and Mechanism Study
Cardiometabolic Diseases: Therapeutic Targets Discovery and Mechanism Study
12k
Total downloads
45k
Total views and downloads
Articles
REVIEW
Published on 17 Mar 2025
The role of Perilipin 5 in pathological myocardial remodeling
doi 10.3389/fphar.2025.1526494
- 1,511 views
ORIGINAL RESEARCH
Published on 17 Mar 2025
The relationship between remnant cholesterol and young-onset myocardial infarction in patients with type 2 diabetes: a retrospective study
doi 10.3389/fphar.2025.1512662
- 948 views
REVIEW
Published on 06 Mar 2025
Targeting miRNA with flavonoids: unlocking novel pathways in cardiovascular disease management
doi 10.3389/fphar.2025.1532986
- 1,388 views
- 1 citation
ORIGINAL RESEARCH
Published on 12 Feb 2025
Association between Chinese visceral adiposity index and risk of new-onset hypertension in middle-aged and older adults with prediabetes: evidence from a large national cohort study
doi 10.3389/fpubh.2025.1509898
- 2,029 views
REVIEW
Published on 10 Jan 2025
Interplay between energy metabolism and NADPH oxidase-mediated pathophysiology in cardiovascular diseases
doi 10.3389/fphar.2024.1503824
- 1,708 views
- 2 citations
REVIEW
Published on 07 Jan 2025
Gallic acid: a dietary metabolite’s therapeutic potential in the management of atherosclerotic cardiovascular disease
doi 10.3389/fphar.2024.1515172
- 2,307 views
- 5 citations
REVIEW
Published on 17 Dec 2024
Anticoagulation approach in morbid obesity: a comprehensive review on venous thromboembolism management
doi 10.3389/fphar.2024.1457280
- 4,866 views
- 1 citation
ORIGINAL RESEARCH
Published on 13 Dec 2024
Comparative analysis of mineralocorticoid receptor antagonists and renin-angiotensin system inhibitors/angiotensin receptor neprilysin inhibitor in heart failure with mildly reduced ejection fraction
doi 10.3389/fphar.2024.1507326
- 1,231 views
- 1 citation
ORIGINAL RESEARCH
Published on 06 Dec 2024
Metabolomics study of APETx2 post-conditioning on myocardial ischemia-reperfusion injury
doi 10.3389/fphar.2024.1470142
- 1,101 views
ORIGINAL RESEARCH
Published on 20 Nov 2024
Astragaloside IV alleviates inflammation and improves myocardial metabolism in heart failure mice with preserved ejection fraction
doi 10.3389/fphar.2024.1467132
- 2,777 views
- 5 citations
ORIGINAL RESEARCH
Published on 09 Oct 2024
Association between cardiometabolic index and kidney stone from NHANES: a population-based study
doi 10.3389/fendo.2024.1408781
- 3,902 views
- 3 citations
